Copyright © Inderes 2011 - present. All rights reserved.

Active Biotech

0.08 SEK

+50.64 %

Less than 1K followers

ACTI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

+50.64 %
+50.64 %
+79.78 %
+79.78 %
-35.58 %
+16.45 %
-70.54 %
-81.26 %
-98.01 %

Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The project portfolio includes both small, orally active immunomodulatory molecules and antibody-based immunotherapy. The company operates globally. Active Biotech was founded in 1998 and is headquartered in Lund.

Read more
Market cap
218M SEK
Turnover
17.04M SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7/5
2026

Interim report Q1'26

20/5
2026

General meeting '26

20/8
2026

Interim report Q2'26

ShowingAll content types
Third party research

Active Biotech: Studie startar på nytt - Analysguiden

Den amerikanska delen av Active Biotechs myelofibros-projekt har fått tillstånd att starta rekrytering av nya patienter efter ett tio månader långt uppehåll. Vi räknar inom kort med omstart för även den europeiska studien. Under året ser vi också en ...

Active Biotech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.